228 related articles for article (PubMed ID: 24992189)
1. Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK/MAPK pathway.
Zhou Q; Gui S; Zhou Q; Wang Y
PLoS One; 2014; 9(7):e101132. PubMed ID: 24992189
[TBL] [Abstract][Full Text] [Related]
2. A novel all-trans retinoid acid derivative N-(3-trifluoromethyl- phenyl)- retinamide inhibits lung adenocarcinoma A549 cell migration through down-regulating expression of myosin light chain kinase.
Fan TT; Cheng Y; Wang YF; Gui SY; Chen FH; Zhou Q; Wang Y
Asian Pac J Cancer Prev; 2014; 15(18):7687-92. PubMed ID: 25292047
[TBL] [Abstract][Full Text] [Related]
3. Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK.
Zou DB; Wei X; Hu RL; Yang XP; Zuo L; Zhang SM; Zhu HQ; Zhou Q; Gui SY; Wang Y
Asian Pac J Cancer Prev; 2015; 16(14):5835-42. PubMed ID: 26320459
[TBL] [Abstract][Full Text] [Related]
4. New insights into 4-amino-2-tri-fluoromethyl-phenyl ester inhibition of cell growth and migration in the A549 lung adenocarcinoma cell line.
Wang H; Gui SY; Chen FH; Zhou Q; Wang Y
Asian Pac J Cancer Prev; 2013; 14(12):7265-70. PubMed ID: 24460286
[TBL] [Abstract][Full Text] [Related]
5. Melatonin inhibits colon cancer RKO cell migration by downregulating Rho‑associated protein kinase expression via the p38/MAPK signaling pathway.
Liu Z; Zou D; Yang X; Xue X; Zuo L; Zhou Q; Hu R; Wang Y
Mol Med Rep; 2017 Dec; 16(6):9383-9392. PubMed ID: 29152648
[TBL] [Abstract][Full Text] [Related]
6. A novel all-trans retinoid acid derivatives inhibits the migration of breast cancer cell lines MDA-MB-231 via myosin light chain kinase involving p38-MAPK pathway.
Wang B; Yan Y; Zhou J; Zhou Q; Gui S; Wang Y
Biomed Pharmacother; 2013 Jun; 67(5):357-62. PubMed ID: 23602051
[TBL] [Abstract][Full Text] [Related]
7. All-Trans Retinoic Acid Inhibits Human Colorectal Cancer Cells RKO Migration via Downregulating Myosin Light Chain Kinase Expression through MAPK Signaling Pathway.
Zuo L; Yang X; Lu M; Hu R; Zhu H; Zhang S; Zhou Q; Chen F; Gui S; Wang Y
Nutr Cancer; 2016 Oct; 68(7):1225-33. PubMed ID: 27564600
[TBL] [Abstract][Full Text] [Related]
8. Fructus phyllanthi tannin fraction induces apoptosis and inhibits migration and invasion of human lung squamous carcinoma cells in vitro via MAPK/MMP pathways.
Zhao HJ; Liu T; Mao X; Han SX; Liang RX; Hui LQ; Cao CY; You Y; Zhang LZ
Acta Pharmacol Sin; 2015 Jun; 36(6):758-68. PubMed ID: 25864648
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathways.
Ni L; Feng Y; Wan H; Ma Q; Fan L; Qian Y; Li Q; Xiang Y; Gao B
Oncol Rep; 2012 Mar; 27(3):783-90. PubMed ID: 22089256
[TBL] [Abstract][Full Text] [Related]
10. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells.
Wu KC; Yang ST; Hsia TC; Yang JS; Chiou SM; Lu CC; Wu RS; Chung JG
Anticancer Res; 2012 Nov; 32(11):4833-42. PubMed ID: 23155249
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.
Abdulrahman N; Jaballah M; Poomakkoth N; Riaz S; Abdelaziz S; Issa A; Mraiche F
Mol Cell Biochem; 2016 Jul; 418(1-2):21-9. PubMed ID: 27236820
[TBL] [Abstract][Full Text] [Related]
12. β-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: The role of MAPK, ROS activation and glutathione depletion.
Wu TT; Lu CL; Lin HI; Chen BF; Jow GM
Oncol Rep; 2016 Jan; 35(1):227-34. PubMed ID: 26530631
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway.
Fong YC; Liu SC; Huang CY; Li TM; Hsu SF; Kao ST; Tsai FJ; Chen WC; Chen CY; Tang CH
Lung Cancer; 2009 Jun; 64(3):263-70. PubMed ID: 18996613
[TBL] [Abstract][Full Text] [Related]
14. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells.
Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X
J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425
[TBL] [Abstract][Full Text] [Related]
15. HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways.
Fan C; Pan Y; Yang Y; Di S; Jiang S; Ma Z; Li T; Zhang Z; Li W; Li X; Reiter RJ; Yan X
J Pineal Res; 2015 Oct; 59(3):321-33. PubMed ID: 26184924
[TBL] [Abstract][Full Text] [Related]
16. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression.
Yan KH; Lee LM; Yan SH; Huang HC; Li CC; Lin HT; Chen PS
Chem Biol Interact; 2013 May; 203(3):580-7. PubMed ID: 23566884
[TBL] [Abstract][Full Text] [Related]
17. FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.
Wang K; Zhu X; Zhang K; Zhu L; Zhou F
Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):804-9. PubMed ID: 27521795
[TBL] [Abstract][Full Text] [Related]
18. Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways.
Chen YY; Chou PY; Chien YC; Wu CH; Wu TS; Sheu MJ
Phytomedicine; 2012 Jun; 19(8-9):768-78. PubMed ID: 22464013
[TBL] [Abstract][Full Text] [Related]
19. A novel compound RY10-4 induces apoptosis and inhibits invasion via inhibiting STAT3 through ERK-, p38-dependent pathways in human lung adenocarcinoma A549 cells.
Xue P; Zhao Y; Liu Y; Yuan Q; Xiong C; Ruan J
Chem Biol Interact; 2014 Feb; 209():25-34. PubMed ID: 24300195
[TBL] [Abstract][Full Text] [Related]
20. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]